Showing 31-40 of 448 results
-
The quest for a coronavirus supervaccine
AFP, Published on 25/04/2022
» PARIS: As vaccine makers rush to stamp out new Covid-19 variants, some scientists have set their sights higher, aiming for a universal coronavirus vaccine that could tackle any future strains and possibly even stave off another pandemic.
-
WHO 'strongly recommends' Pfizer's Covid pill
AFP, Published on 22/04/2022
» GENEVA: The World Health Organization said Friday it "strongly recommended" Pfizer's Covid-19 antiviral pill Paxlovid for patients with milder forms of the disease who were still at a high risk of hospitalisation.
-
China locks down city of 9 million as virus ripples across country
AFP, Published on 22/03/2022
» BEIJING: China locked down an industrial city of nine million people overnight and reported more than 4,000 virus cases on Tuesday, as the nation's "zero-Covid" strategy is confronted by an Omicron wave.
-
Los Angeles suing Monsanto for chemicals in waterways
AFP, Published on 08/03/2022
» LOS ANGELES - Chemical company Monsanto found itself in the horns of yet another lawsuit Monday, as Los Angeles sued the firm for allegedly knowingly polluting waterways in one of the biggest cities in the United States.
-
Covid booster efficacy wanes significantly by fourth month: US study
AFP, Published on 12/02/2022
» WASHINGTON: The efficacy of third doses of the Pfizer and Moderna mRNA vaccines wanes substantially by the fourth month after administration, a new study by the US Centers of Disease Control and Prevention (CDC) said Friday.
-
Pfizer sees Covid-19 drug sales topping $50bn in 2022
AFP, Published on 09/02/2022
» NEW YORK - Pfizer forecast more than $50 billion in 2022 sales for its Covid-19 vaccine and therapeutic on Tuesday as the pharmaceutical giant reported a more than doubling of annual profits on strong sales of its innoculation.
-
Pfizer seeks US approval of Covid vaccine for children under 5
AFP, Published on 02/02/2022
» WASHINGTON - Pfizer and BioNTech said Tuesday they are seeking emergency authorization from US health regulators for use of their Covid vaccine for children aged over six months and under five years.
-
Unilever won't up £50bn offer for GSK-Pfizer unit
AFP, Published on 20/01/2022
» LONDON: Consumer goods giant Unilever on Wednesday said it would not increase a £50-billion offer for the consumer healthcare unit owned by pharmaceutical groups GlaxoSmithKline and Pfizer.
-
Fourth jab 'partially' effective against Omicron: Israeli study
AFP, Published on 18/01/2022
» JERUSALEM: Fourth doses of the Pfizer and Moderna vaccines against Covid-19 are only "partially" effective for the Omicron variant of the virus, the authors of an Israeli trial said Monday.
-
Brazil begins vaccinating young children despite Bolsonaro objection
AFP, Published on 15/01/2022
» SAO PAULO - Brazil began vaccinating children aged five to 11 against Covid-19 on Friday after the move was approved, despite objections from President Jair Bolsonaro.
Your recent history
-
Recently searched
-
Recently viewed links